1. Prenatal diagnosis of Proteus syndrome: Diagnosis of an <scp> AKT1 </scp> mutation from amniocytes
- Author
-
Marissa Vawter-Lee, Robert J. Hopkin, Leandra K. Tolusso, Stefanie Riddle, Maria A. Calvo-Garcia, Vivian Hwa, Nicki Smith, Howard M. Saal, Qiaoning Guan, Mounira Habli, Karin S. Bierbrauer, and Katherine Abell
- Subjects
0301 basic medicine ,Embryology ,Pathology ,medicine.medical_specialty ,Health, Toxicology and Mutagenesis ,AKT1 ,Prenatal diagnosis ,030105 genetics & heredity ,Toxicology ,medicine.disease_cause ,Proteus Syndrome ,03 medical and health sciences ,symbols.namesake ,Pregnancy ,Prenatal Diagnosis ,medicine ,Humans ,Megalencephaly ,Exome sequencing ,Sanger sequencing ,Mutation ,business.industry ,medicine.disease ,Phenotype ,Proteus syndrome ,030104 developmental biology ,Pediatrics, Perinatology and Child Health ,symbols ,Female ,business ,Proto-Oncogene Proteins c-akt ,Developmental Biology - Abstract
Proteus syndrome is a mosaic genetic overgrowth disorder caused by a postzygotic, mosaic activating mutation in AKT1. Rare prenatal presentations include segmental tissue overgrowth, and skeletal and CNS anomalies. We present the first report of prenatally diagnosed and molecularly confirmed Proteus syndrome. Prenatal imaging identified megalencephaly, brain and eye malformations, focal soft tissue enlargement, and ambiguous genitalia. Exome sequencing performed on cultured amniocytes demonstrated an AKT1 pathogenic variant consistent with Proteus syndrome, and postnatal examination confirmed the diagnosis. Postnatal Sanger sequencing could not identify the AKT1 pathogenic variant. This case underscores the importance of prenatal exome sequencing on cultured amniocytes for mosaic overgrowth disorders, as well as provides additional information on the prenatal phenotype of Proteus syndrome, and highlights the impact of prenatal diagnosis on postnatal management.
- Published
- 2020
- Full Text
- View/download PDF